Copyright: ©Author(s) 2026.
World J Stem Cells. Aug 26, 2026; 18(8): 121648
Published online Aug 26, 2026. doi: 10.4252/wjsc.121648
Published online Aug 26, 2026. doi: 10.4252/wjsc.121648
Table 3 Comparison between mesenchymal stem cell therapy and myoblast cell sheet therapy
| Item | MSC therapy | Myoblast cell sheet therapy |
| Main effect | Immunomodulation and improvement of the local inflammatory environment | Local repair with potential muscle layer reconstruction |
| Delivery | Usually local injection; cells may be easily lost | Transplanted as a cell sheet, with better local retention |
| Repair pattern | Regulatory repair | Potential structural support and repair |
| Evidence in CD | Supported by several clinical studies | Direct evidence remains limited |
| Potential role | Promotes fistula closure and inflammation control | May support tissue reconstruction in complex fistulas |
- Citation: Zhang BL, Kobayashi S, Li LY, Li TY, Ogawa S, Miyamoto D, Hasegawa K, Yamaguchi S, Adachi T, Eguchi S, Kanetaka K. From mesenchymal stem cells to myoblast cell sheets: A next-generation regenerative concept for fistulizing Crohn’s disease. World J Stem Cells 2026; 18(8): 121648
- URL: https://www.wjgnet.com/1948-0210/full/v18/i8/121648.htm
- DOI: https://dx.doi.org/10.4252/wjsc.121648